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marker motion during an arc with irregular breathing. Intrafraction 
motion caused a mean 3D target position error of 3.3 mm, resulting in 
a mean D95 reduction of 6.6% over all fractions. The D95 reduction 
correlated with the mean 3D target position error during a fraction (p 
< 0.001, Fig. B). 
Conclusions: Kilovoltage imaging for detailed motion monitoring and 
dose reconstruction during VMAT liver SBRT was demonstrated for the 
first time. Large dosimetric impact of intrafraction tumor motion was 
observed. Although all patients received the prescribed dose (since 
dose is prescribed to the 67% level) the results show that intrafraction 
motion adaptation is warranted to maximize the CTV dose, especially 
for SBRT treatments where the convention has been to prescribe a 
peaked non-uniform PTV dose that gradually decreases outside the 
CTV. 
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Purpose/Objective: Markers are often used to track lung tumors. 
However markers placed outside the tumor may not move 
synchronously to the tumor during breathing thereby potentially 
introducing errors in tumor tracking. The purpose of this study is to 
identify factors which influence non-synchronous marker motion, and 
to evaluate methods to exclude markers for tumor tracking in order to 
minimize the tracking error. 
Materials and Methods: Data of 53 patients with 64 tumors were 
studied. Marker and tumor motion was assessed using a 4DCT scan. In-
house developed software was used to automatically register the 
tumor in the end-expiration phase to the tumor in the end-inspiration 
phase. Non-synchronous marker motion was defined by the vector 
connecting a marker on the end-expiration phase CT-scan to the 
corresponding marker on the registered end-inspiration phase CT-
scan. The tracking error was defined as the difference in the center of 
mass of the included markers on the end-expiration CT-scan and the 
registered end-inspiration CT-scan. Multivariate linear regression 
analysis was performed to evaluate the association between non-
synchronous marker motion and 1) the amplitude of tumor motion, 2) 
the distance between the marker and the tumor edge, 3) the location 
of the marker relative to the tumor (same lobe or different lobe) 4) 
the type of marker (coil or percutaneously-placed marker) and 5) the 
location of the tumor (against the chest wall or not). We examined if 
the tracking error could be reduced by excluding markers for tumor 
tracking based on 1) the distance of the marker to the tumor edge and 
2) the extent of non-synchronous marker motion during breathing as 
determined on the 4DCT scan. The value of the two exclusion 
parameters was varied such that for all patients at least 1 marker was 
available for tracking. 
Results: Non-synchronous marker motion during the breathing cycle 
was 0.2±1.4 mm (mean±1SD) in LR direction, 0.4±1.6 mm in AP 
direction, and -0.3±2.9 mm in CC direction. Factors which significantly 
increased non-synchronous motion were increasing amplitude of tumor 
motion (p<0.01), increasing distance between the marker and the 
tumor edge (p<0.01), and the location of the tumor against the chest 
wall (p<0.01). The tracking error due to non-synchronous tumor 
marker motion could be reduced by excluding markers based on the 
distance of the marker to the tumor edge (fig 1a). More effective was 
excluding markers based on their non-synchronous motion during 
breathing as assessed by 4DCT. By excluding markers with non-
synchronous motion ≥3.5 mm, the standard deviation of the tracking 
error was reduced from 1.4 to 0.8 mm (LR), 1.2 to 1.0 mm (AP), 2.0 to 
0.9 mm (CC) (fig 1b). 
 
Conclusions: Precise tumor tracking requires a 4DCT scan to identify 
and exclude markers with non-synchronous motion. This allows a 
reduction in the standard deviation of the tracking error by as much 
as 50%. Exclusion of markers based on the distance to the tumor edge 
was less effective. 
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Purpose/Objective: 4D CBCT images acquired on linac-based scanners 
are usually reconstructed by extracting the motion information from 
the 2D projections (or an external surrogate signal), and binning the 
individual projections into one or multiple breathing phases. In this 
‘after-the-fact’ binning approach, however, imaging dose might be 
administered in breathing phases not desired for reconstruction. For 
4D reconstructions, the image quality can be compromised by an 
uneven distribution of projections over respiratory phases and angles. 
We have therefore developed control software which actively triggers 
2D projections based on the predicted position of the tumour. The 
prediction is derived from internal tumour positions reported by the 
Calypso electromagnetic (EM) tracking system. 
Materials and Methods: Due to the radio emissions of the EM-array, it 
is impossible to simultaneously operate EM tracking and acquire 
artefact-free images without shielding the detector. For this study we 
have used a very thin aluminium Faraday 'cage' for the detector that 
removes most EM-induced artefacts. We have also implemented new 
control software which receives a continuous stream (10 Hz) of 3D 
tumour positions from the EM-device. The position information of a 
sliding training window is used to predict a new position (120 ms in 
the future) using a support vector machine. The predicted position is 
then classified as e.g. peak-inhale according to the amplitude of the 
last respiratory cycle. Depending on the desired breathing phase and 
maximum angular spacing between images, a new 2D projection is 
triggered. We have used a lung phantom moving on a sin4 trajectory 
with 15 mm amplitude and a 3.5 sec period for our study. A tumour 
model made from RW3 and the EM transponders were implanted into 
the phantom. For kV images which were superimposed by the 
projection of the EM-array (i.e. its internal antenna), image 
processing was used to replace pixels depicting the antenna by 
neighbouring ‘good’ pixels. 3D images were then reconstructed using 
an FDK algorithm provided by Siemens.  
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Results: We were able to demonstrate the feasibility of our new 
acquisition technique for peak-inhale only, peak-exhale only, and mid-
ventilation only short (200°) and full scanning protocols. In the figure, 
a significant reduction in motion-related artefacts at the tumour 
surface is demonstrated. Reconstruction artefacts stemming from the 
presence of the EM-array were greatly reduced. Inherently, the 
method leads to a smooth distribution of projection angles over the 
entire gantry rotation. A typical CTDI imaging dose for a peak-exhale 
(360°, 375 fr., 5 min)/peak-inhale (200°, 106 fr., 2:47 min) protocol is 
~8/~2 mGy. 
 
  
Conclusions: We have implemented a new dose-saving 4D CBCT 
scanning protocol which reduces motion-artefacts by selecting the 
breathing phase(s) desired for reconstruction prior to image 
acquisition. We are currently implementing the acquisition of multiple 
phases in one gantry rotation. 
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Purpose/Objective: To develop and evaluate a tumour tracking 
method for the dynamic localization of extra-cranial targets during 
radiotherapy treatments, providing the continuous monitoring and 
compensation of intra-fraction organ motion due to breathing. The 
proposed approach is based on external surface surrogates estimated 
from non-invasive optical devices, and on patient-specific adaptive 
motion models derived from time-resolved planning and in-room X-ray 
imaging systems. 
Materials and Methods: A patient-specific motion model, 
parameterized as a function of the respiratory tumour baseline, 
amplitude and phase, is estimated from 4D CT planning images, by 
applying B-spline deformable registration between each 4D CT phase 
and the mid-position CT volume.The tumour baseline is adapted at 
each treatment fraction according to daily information on target 
localization derived from volumetric CBCT images. The breathing 
amplitude and phase parameters are retrieved from the external 
surface motion, acquired with 3D surface imaging systems. 
Deformable mesh registration is applied to derive the spatial 
correspondence between markerless optical surfaces. The obtained 3D 
trajectories of all thoraco-abdominal surface points are summarized 
into a single respiratory surrogate signal through k-means clustering 
techniques. The instantaneous values of the respiratory phase are 
extracted from the surface surrogate using the Hilbert transform. The 
amplitude scaling factor is obtained by comparing surface motion 
amplitudes during treatment planning and delivery. The adapted 
breathing parameters are integrated in the 4D CT motion model to 
estimate intra-fraction 3D tumor motion. 
Results: The developed tumour tracking method was tested on a 
clinical database of seven lung cancer patients, including the 
synchronized information on the external surface and internal tumour 
breathing motion during CBCT scans. About 30 seconds of 
synchronized acquisition of CBCT projections and optical surfaces, 
captured with the VisionRT system, were analyzed for each patient. 
The tumour trajectories estimated from surface displacement 
combined with the a priori 4D CT motion model were compared to the 
real target trajectories identified on CBCT images. The resulting 
absolute differences between real and estimated tumour motion 
ranged between 0.7 and 2.4 mm, with median values of 1.5 mm both 
along the horizontal and vertical image dimensions (Table 1). The 
measured phase shifts did not exceed the 7% of the breathing cycle 
length. 
 
  
Conclusions: The developed tumor tracking method proved to be 
effective in estimating tumour motion from the external surface 
displacement even in presence of breathing irregularities, as depicted 
in Figure 1. The innovative methodological aspects, related to the use 
of patient-specific adaptive motion models and to the redundancy of 
markerless surface data, are put forward to improve the accuracy and 
robustness of targeting techniques for intra-fraction organ motion 
compensation. 
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Purpose/Objective: In radiotherapy, fiducial markers are often 
implanted in the liver and used as x-ray visible surrogates for the 
tumour position. The basic assumption is that the tumour maintains a 
constant position relative to the marker throughout the treatment 
course. The aim of this study was to investigate the validity of this 
assumption by quantifying the geometric accuracy by which one 
implanted marker can predict the position of another marker in the 
liver.  
Materials and Methods: 26 patients with 2-3 implanted gold markers 
received stereotactic body radiation therapy to liver lesions in 3-6 
treatment fractions. At each fraction a cone-beam CT (CBCT) scan 
was acquired and used for marker based patient setup. After the 
treatments each marker was segmented in the projections of the 
CBCT scans, and the resulting 2D marker trajectories were used to 
estimate the 3D trajectory of each marker in patientspace by a 
probability based method. In total 198 3D marker trajectories with a 
mean duration of 51 seconds were recorded at 11 Hz over 90 
treatment fractions. The markers in the data set constituted 54 
marker pairs in total. For each marker pair, the error in estimating 
the 3D position of one marker from the 3D position of the other 
marker was calculated for each time point as the difference in the 3D 
shifts the two markers away from their respective mean positions. The 
root-mean-square (RMS) of this error was calculated for each marker 
pair as a measure for the intrafraction prediction error, during all 
fractions. Similarly, the interfraction RMS estimation error was 
calculated for each marker pair from the changes in the relative 3D 
mean marker positions from fraction to fraction.  
Results: The 3D position of an implanted marker was estimated from 
the position of another marker with a mean RMS error of 0.35 (LR), 
0.59 mm (CC), 0.47 mm (AP), and 0.86 +-0.57 mm (3D) intra-
fractionally, and of 0.52 mm (LR), 0.60 mm (CC), 0.59 mm (AP), and 
